Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Pheochromocytoma
Stage/Subtype:  recurrent pheochromocytoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-3 of 3 for your search:
Start Over
Iobenguane I-131 in Treating Patients with Recurrent Neuroblastoma, Malignant Pheochromocytoma or Malignant Paraganglioma
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 1
Trial IDs: 04-148, NCI-2016-00955, MSKCC-04148, NCT00107289
Iobenguane I 131 in Treating Patients with Relapsed or Refractory Neuroblastoma or Metastatic Pheochromocytoma
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 1 and over
Trial IDs: 2012LS107, NCI-2013-01933, NCT01850888
Cabozantinib-s-malate in Treating Patients with Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0081, NCI-2014-02607, NCT02302833
Start Over